Log In
Print
BCIQ
Print
Print this Print this
 

ME-143 (formerly NV-143)

  Manage Alerts
Collapse Summary General Information
Company Novogen Ltd.
DescriptionDerivative of Triphendiol, a synthetic phenoxodiol analog
Molecular Target
Mechanism of Action 
Latest Stage of DevelopmentPhase I
IndicationSolid tumors
Partner

MEI Pharma Inc.
 Product Details
 Archive Items are loading loading
Get a free BioCentury trial today